Cargando…

Effect of everolimus on multifocal micronodular pneumocyte hyperplasia in tuberous sclerosis complex

Multifocal micronodular pneumocyte hyperplasia (MMPH) is a benign proliferation of alveolar type II cells presenting as multiple pulmonary nodules at chest imaging, which is frequently seen in patients with tuberous sclerosis complex (TSC). We report a case of a woman with TSC and MMPH who received...

Descripción completa

Detalles Bibliográficos
Autores principales:	Daccord, Cécile, Nicolas, Aymeric, Demicheli, Rita, Chehade, Hassib, Hottinger, Andreas F., Beigelman, Catherine, Lazor, Romain
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7720070/ https://www.ncbi.nlm.nih.gov/pubmed/33312857 http://dx.doi.org/10.1016/j.rmcr.2020.101310

Ejemplares similares

Multifocal Micronodular Pneumocyte Hyperplasia with Tuberous Sclerosis
por: Taniguchi, Hirokazu, et al.
Publicado: (2016)

Resolution of multifocal micronodular pneumocyte hyperplasia with everolimus in a patient with tuberous sclerosis complex
por: Shoji, Tetsuaki, et al.
Publicado: (2021)

Multifocal micronodular pneumocyte hyperplasia: A “touch-me-not” pulmonary lesion in tuberous sclerosis complex
por: Aswani, Yashant, et al.
Publicado: (2018)

Multifocal micronodular pneumocyte hyperplasia (MMPH) in a patient with tuberous sclerosis-evidence for long term stability
por: Pannu, Bibek S., et al.
Publicado: (2017)

Tuberous sclerosis diagnosed by incidental computed tomography findings of multifocal micronodular pneumocyte hyperplasia: a case report
por: Ishii, Makoto, et al.
Publicado: (2012)

Difficulties in Differentiating Osteosclerosis in Patients With Multifocal Micronodular Pneumocyte Hyperplasia and Cancer
por: Kumamoto, Makiko, et al.
Publicado: (2023)

Multifocal micronodular pneumocyte hyperplasia lacking typical clinical features of the tuberous sclerosis complex: a case report and literature review
por: Li, Shan, et al.
Publicado: (2022)

13-year-old tuberous sclerosis patient with renal cell carcinoma associated with multiple renal angiomyolipomas developing multifocal micronodular pneumocyte hyperplasia
por: Behnes, Carl Ludwig, et al.
Publicado: (2013)

Multifocal micronodular pneumocyte hyperplasia with a novel mutation in TSC1: a case report
por: Li, Ai, et al.
Publicado: (2021)

Multiple Micronodular Pneumocyte Hyperplasia (MMPH): A Less-Known Presentation of Tuberous Sclerosis Complex Related Lung Disease
por: Lembrechts, Matthias, et al.
Publicado: (2023)

Familial multifocal micronodular pneumocyte hyperplasia with a novel splicing mutation in TSC1: Three cases in one family
por: Shoji, Tetsuaki, et al.
Publicado: (2019)

Lymphangioleiomyomatosis, multifocal micronodular pneumocyte hyperplasia, and sarcoidosis: more pathological findings in the same chest CT, or a single pathological pathway?
por: Di Marco, Fabiano, et al.
Publicado: (2017)

Pitfalls in diagnosis of infiltrative lung disease by CT
por: Du Pasquier, Céline, et al.
Publicado: (2019)

Everolimus for treatment of tuberous sclerosis complex‐associated neuropsychiatric disorders
por: Krueger, Darcy A., et al.
Publicado: (2017)

Prevalence of Birt-Hogg-Dubé Syndrome Determined Through Epidemiological Data on Spontaneous Pneumothorax and Bayes Theorem
por: Muller, Marie-Eve, et al.
Publicado: (2021)

Fibrous Plaque of the Eyelid in a Patient with Tuberous Sclerosis Responding to Everolimus
por: Park, Sung-Min, et al.
Publicado: (2018)

Everolimus dosing recommendations for tuberous sclerosis complex–associated refractory seizures
por: Franz, David N., et al.
Publicado: (2018)

Everolimus induced organizing pneumonia in a patient with tuberous sclerosis complex
por: Lanfranco, Julio, et al.
Publicado: (2021)

Relationship between pneumonitis induced by immune checkpoint inhibitors and the underlying parenchymal status: a retrospective study
por: Pozzessere, Chiara, et al.
Publicado: (2020)

Probability of sporadic lymphangioleiomyomatosis in women presenting with spontaneous pneumothorax
por: Suter, Audrey, et al.
Publicado: (2023)

Everolimus and intensive behavioral therapy in an adolescent with tuberous sclerosis complex and severe behavior()()()
por: Gipson, Tanjala T., et al.
Publicado: (2013)

Erratum: Fibrous Plaque of the Eyelid in a Patient with Tuberous Sclerosis Responding to Everolimus
por: Park, Sung-Min, et al.
Publicado: (2018)

Effect and Complications of Everolimus Use for Giant Cardiac Rhabdomyomas with Neonatal Tuberous Sclerosis
por: Shibata, Yuka, et al.
Publicado: (2019)

Multiple osteoblastomas in a child with Cushing syndrome due to bilateral adrenal micronodular hyperplasias
por: Yu, Hyeoh Won, et al.
Publicado: (2016)

SUN-387 ACTH-Independent Cushing Syndrome from Pregnancy-Induced Micronodular Hyperplasia
por: Affinati, Alison, et al.
Publicado: (2019)

Pneumocyte injury and ubiquitin-positive pneumocytes in interstitial lung diseases*
por: Yamada, Tsutomu, et al.
Publicado: (2015)

TuberOus SClerosis registry to increAse disease awareness (TOSCA) Post-Authorisation Safety Study of Everolimus in Patients With Tuberous Sclerosis Complex
por: Kingswood, J. Chris, et al.
Publicado: (2021)

Everolimus for the treatment of refractory seizures associated with tuberous sclerosis complex (TSC): current perspectives
por: Overwater, Iris E, et al.
Publicado: (2019)

The Effect of Everolimus on Subependymal Giant Cell Astrocytoma (SEGA) in Children with Tuberous Sclerosis Complex
por: BAKHTIARY, Hassan, et al.
Publicado: (2021)

Sequential everolimus for angiomyolipoma associated with tuberous sclerosis complex: a prospective cohort study
por: Gu, Liangyou, et al.
Publicado: (2021)

Low-Dose Everolimus Maintenance Therapy for Renal Angiomyolipoma Associated With Tuberous Sclerosis Complex
por: Luo, Cong, et al.
Publicado: (2021)

Stick or twist: Everolimus for seizures in tuberous sclerosis complex during the COVID-19 pandemic
por: Moloney, Patrick B., et al.
Publicado: (2021)

Individualized everolimus treatment for tuberous sclerosis-related angiomyolipoma promotes treatment adherence and response
por: Chung, Noelle K X, et al.
Publicado: (2022)

Comparative clinicopathological and immunohistochemical study of micronodular thymoma and micronodular thymic carcinoma with lymphoid stroma
por: Liu, Ping Ping, et al.
Publicado: (2022)

Birt–Hogg–Dubé syndrome
por: Daccord, Cécile, et al.
Publicado: (2020)

Profile of everolimus in the treatment of tuberous sclerosis complex: an evidence-based review of its place in therapy
por: Capal, Jamie K, et al.
Publicado: (2016)

Management of everolimus-associated adverse events in patients with tuberous sclerosis complex: a practical guide
por: Davies, Mark, et al.
Publicado: (2017)

Pilot study evaluating everolimus molecular mechanisms in tuberous sclerosis complex and focal cortical dysplasia
por: Leitner, Dominique F., et al.
Publicado: (2022)

Everolimus as a therapeutic option in refractory epilepsy in children with tuberous sclerosis: a systematic review
por: Menezes, Catarina Ester Gomes, et al.
Publicado: (2023)

Effectiveness and safety of everolimus treatment in patients with tuberous sclerosis complex in real-world clinical practice
por: Cockerell, Ine, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_2u6ehp4j5dojembum0bug1gmpi